摘要
目的探讨Silverhawk斑块旋切、国产紫杉醇药物涂层球囊(DCB)和金属裸支架治疗下肢动脉闭塞的临床疗效。方法前瞻性选取2019年1月~2021年12月我院收治的下肢动脉闭塞病人101例,按照随机对照法将其分为两组,A组进行Silverhawk斑块旋切治疗,B组在A组基础上加以国产紫杉醇DCB+金属裸支架治疗,对两组的临床指标、临床驱动靶病变再次血运重建率、内皮素(ET)-1、一氧化氮(NO)以及血浆P选择素水平进行比较。结果B组病人治疗后的临床指标优于A组,治疗后12小时两组病人的血浆P选择素、ET-1水平降低,治疗后12小时两组病人的NO水平上升,且治疗后B组病人的血浆P选择素、ET-1及NO水平均优于A组,B组病人术后6个月、12个月的再次血运重建率均低于A组,差异均有统计学意义(P<0.05)。结论应用Silverhawk斑块旋切+国产紫杉醇DCB+金属裸支架治疗下肢动脉闭塞的临床疗效显著,改善病人的血管通畅率、ET-1、NO以及血浆P选择素水平,提高其踝肱指数,降低靶病变血流重建率。
Objective This article analyzes the clinical efficacy of silverhawk plaque cyclotomy,Drug-coated balloon(DCB)and bare metal stent in the treatment of patients with lower extremity arterial occlusion.Method A total of 101 patients with lower extremity arterial occlusion admitted to our hospital from January 2019 to December 2021 were prospectively selected and divided into group A for silverhawk plaque rotary cutting treatment by randomized controlled method.Group B was treated with domestic paclitaxel DCB+bare metal stent on the basis of group A,and then its clinical indicators,clinical target lesion revascularization rate,ET-1,NO and plasma P-selectin levels were compared.Results The clinical indexes of group B were significantly better than those of group A(P<0.05).The levels of plasma P-selectin and ET-1 in the two groups were significantly decreased at 12 h after treatment(P<0.05).The levels of NO in the two groups were significantly increased at 12 h after treatment(P<0.05),and the levels of plasma P-selectin,ET-1 and NO in group B were significantly better than those in group A(P<0.05).The revascularization rates at 6 months and 12 months after operation in group B were significantly lower than those in group A(P<0.05).Conclusion Application of silverhawk plaque rotary cutting+domestic paclitaxel DCB+bare metal stent combined treatment of lower extremity arterial occlusion of clinical curative effect is remarkable,improve the patient’s vascular patency rate,ET-1,NO and plasma P-selectin level,improve the ankle brachial index,reduce the target lesion blood flow reconstruction rate,is worth promoting.
作者
冯波
孙显飞
刘文菊
张洁
赵鸿志
FENG Bo;SUN Xianfei;LIU Wenju(Department of vascular surgery,Qingdao Fuwai Hospital,Qingdao 266000,China)
出处
《临床外科杂志》
2023年第5期479-481,共3页
Journal of Clinical Surgery